Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Phages and cancer immunity Gut bacteria are involved in the education of T cell immune responses, and the intestinal ecosystem influences anticancer immunity. Fluckiger et al. report microbial antigens that might cross-react with antigens associated with tumor cells. They found that a type of intestinal bacteria called enterococci harbor a bacteriophage that modulates immune responses. In mouse models, administration of enterococci containing the bacteriophage boosted T cell responses after treatment with chemotherapy or programmed cell death protein 1 (PD-1) blockade. In humans, the presence of the bacteriophage was associated with improved survival after PD-1 immunotherapy. A fraction of human T cells specific for naturally processed melanoma epitopes appeared to be able to recognize microbial peptides. This “molecular mimicry” may represent cross-reactivity between tumors and microbial antigens. Science , this issue p. 936
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, bacteriophages as therapeutic strategies could modulate the gut microbiota, immunity, and TME [70, 164–166].”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · doi:10.1186/s13045-022-01273-9 · cites this paper as [70]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“an E. hirae strain carrying a prophage from the Siphoviridae family translocates to mLNs and the spleen”
From Impact of the ONCOBIOME network in cancer microbiome research (2025) · cites this paper as [55]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“boosts the T cell-dependent efficacy of cyclophosphamide or PD-1 blockade”
From Impact of the ONCOBIOME network in cancer microbiome research (2025) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“molecular mimicry between microbial and tumor-associated antigens, resulting in cross-reactive T cell responses 55”
From Impact of the ONCOBIOME network in cancer microbiome research (2025) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, the gut microbiome’s vast antigen reservoir may facilitate cross-reactivity between bacterial and tumor antigens, thereby enhancing antitumor immune responses (Fluckiger et al., 2020; Naghavian et al., 2023).”
From Microbiota-centered interventions to boost immune checkpoint blockade therapies (2025) · cites this paper as Fluckiger et al., 2020
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov, A. S., Lesin, V. M., Nikolenko, S. I., Pham, S., Prjibelski, A. D., et al. (2012) · Journal of Computational Biology · doi:10.1089/cmb.2012.0021 · Cited by 25,987
Prokka: rapid prokaryotic genome annotation
Seemann, T. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu153 · Cited by 18,818
Guindon, S., Dufayard, J.-F., Lefort, V., Anisimova, M., Hordijk, W., & Gascuel, O. (2010) · Systematic Biology · doi:10.1093/sysbio/syq010 · Cited by 18,376
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
OrthoMCL: Identification of Ortholog Groups for Eukaryotic Genomes
Li, L., Stoeckert, C. J., & Roos, D. S. (2003) · Genome Research · doi:10.1101/gr.1224503 · Cited by 5,707
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Self-citationAnticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488
Self-citationImmune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345
Cited by
Items 301–400 of 402
Fang, J., Wu, M., Shen, H., Liu, W., & Zhang, T. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1616928 · Cited by 3
Su, P., Tao, Y., Wang, A., & Xiao, Y. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000004476 · Cited by 4
Microbial-derived immunostimulatory small molecule augments anti-PD-1 therapy in lung cancer
Newsome, R. C., Liu, H., Agbodzi, B., Gharaibeh, R. Z., Zhou, L., & Jobin, C. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102519 · Cited by 5
Tumor-associated bacterial effectors: novel frontiers in tumor biology and immunity
Dai, J.-H., Lu, Y.-Q., Feng, S.-Y., Tan, X.-R., Li, L., Zeng, Y.-C., Chen, J., Ma, J., & Liu, N. (2026) · 中国科学通报:英文版 · doi:10.1016/j.scib.2026.04.034 · Cited by 4
Microbiome and cancer: mechanistic insights, diagnostic potential, and therapeutic strategies
Kumar, V., Chaudhary, A., Gautam, M., Verma, P., & Singh, M. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1844436 · Cited by 3
Crespin, A., Bandinelli, P.-A., Bescop, C. L., Buffet, R., de Gunzburg, J., Vitry, F., Zalcman, G., & Cervesi, J. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-sitc2021.278 · Cited by 3
Pett, N., Hunter, M., Garcia, N. A. C., Seo, J. H., Collins, S. R., Rohwer, F. L., Osborne, L. C., & Tropini, C. (2024) · Journal of Visualized Experiments · doi:10.3791/65906 · Cited by 3
Itoh, K., & Matsueda, S. (2024) · Biomedicines · doi:10.3390/biomedicines12040803 · Cited by 4
Development and treatment of colorectal cancer: Insights from multi‐kingdom microbiota
Hong, Y.-M., Song, D., Liu, N., & Wang, H. (2023) · Aging and Cancer · doi:10.1002/aac2.12063 · Cited by 3
A bacterium-derived, cancer-associated immunopeptidome
Perreault, C., Thibault, P., & Kroemer, G. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1918373 · Cited by 3
Self-citationTailoring bacterial taxa for immune cell modulation
Margalit, O., & Boursi, B. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-21-263 · Cited by 3
Editorial for the Special Issue: The Role of the Virome in Health and Disease
Broecker, F. (2021) · Microorganisms · doi:10.3390/microorganisms10010020 · Cited by 3
Human Th17- and IgG3-associated autoimmunity induced by a translocating gut pathobiontPreprint
Gronke, K., Nguyen, M. T., de Souza, N. S., Schumacher, J., Yang, Y., Sonnert, N. D., Leopold, S. R., Martin, A. L., Hallet, R., Richter, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.29.546430 · Cited by 3
Gut markers for metastatic melanoma receiving immunotherapy
Ou, G., Gou, J., Ou, H., Zheng, H., Zhu, Y., Li, J., & Liu, X. (2025) · BMC Cancer · doi:10.1186/s12885-025-14467-4 · Cited by 2
Effect of immune-related intratumoral microbiota and host gene expression on cancer prognosis
Fu, Q., Zhao, N., Li, X., Li, Y., Tian, T., Gao, L., Cao, Y., Wang, L., Liu, J., Wang, F., et al. (2025) · mSystems · doi:10.1128/msystems.01146-25 · Cited by 2
Bacteriophages in gut metagenomes: from analysis to application
Zakharevich, N. V., Strokach, A. A., Egor, S., & Klimina, K. M. (2026) · Virology Journal · doi:10.1186/s12985-026-03069-6 · Cited by 3
Role of Gut Microbiota in Immune Checkpoint Inhibitor Therapy
Fu, Y.-C., Pang, B., & Liang, S. (2026) · Cell Biology International · doi:10.1002/cbin.70148 · Cited by 2
The lethal symbiont: exploring the pathophysiology of cancer
Nolan, E., Li, L., Giampazolias, E., Ombrato, L., & Malanchi, I. (2026) · Physiological Reviews · doi:10.1152/physrev.00019.2025 · Cited by 2
Space, time and microdiversity: towards a resolution revolution in microbiomics
Paoli, L., & Sunagawa, S. (2020) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12897 · Cited by 2
Revamping Hepatocellular Carcinoma Immunotherapy: The Advent of Microbial Neoantigen Vaccines
Liang, J., Liao, Y., Tu, Z., & Liu, J. (2024) · Vaccines · doi:10.3390/vaccines12080930 · Cited by 2
Microbial mimics supersize the pathogenic self-response
Capera, J., & Dustin, M. L. (2024) · Journal of Clinical Investigation · doi:10.1172/jci184046 · Cited by 2
El-Derby, A. M., Schaaf, C. R., Shelkey, E., Cook, K. L., Votanopoulos, K. I., & Söker, S. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2024.1411322 · Cited by 2
The advent of precision nutrigeroscience in cancer: from clinic towards molecular biology
Gao, Z., Liu, Y., Cui, Y., Han, Y., Cao, K., & Wu, Q. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.034 · Cited by 2
Spiking immunotherapy with a bacterial cocktail brings T cells back to the fight
Greathouse, K. L., & Choudhury, A. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100430 · Cited by 2
Sroussi, M., Fluckiger, A., & Zitvogel, L. (2021) · médecine/sciences · doi:10.1051/medsci/2021153 · Cited by 2
Self-citationGenomic characterization of three bacteriophages infecting donkey-derived Escherichia coli
Cui, J., Liu, W., Zhang, C., Zou, L., & Ren, H. (2023) · Virus Genes · doi:10.1007/s11262-023-02008-9 · Cited by 2
The Role Microbiome and Oncolytic Viruses Play in Controlling Cancer
Atiatorme, E., Osafo, R., & Nyarko, S. (2022) · Journal of Cancer and Tumor International · doi:10.9734/jcti/2022/v12i130169 · Cited by 1
Zheng, L., Yang, J., Chen, X., Li, L., & Sun, J. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231163807 · Cited by 1
Gut microbiome and tumor immunotherapy
Vig, M., & Dubey, S. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2024.12.014 · Cited by 3
Ung, W., & Bonavida, B. (2025) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2025058249 · Cited by 1
Talayev, V. Y., Babaykina, O. N., Svetlova, M. V., Заиченко, И. Е., & Kurkova, E. V. (2025) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-trm-17842 · Cited by 1
Prospect of interdisciplinary research on gut microbiota and colorectal cancer immunotherapy
Lu, Y., Zhang, Z., Chen, L., Xue, P., Zhang, Y., Li, Y., & Guo, H. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104832 · Cited by 1
Joshi, D., Chauhan, K., Oberoi, H. S., Kumar, D., & Taneja, N. K. (2026) · Discover Biotechnology · doi:10.1007/s44340-026-00053-2 · Cited by 2
Analysis of intratumoural bacteria: Opportunities and challenges for cancer therapy
Jiang, X., Zhang, C., Cao, S., Peng, Y., Zhao, M., Zhang, X., & Gao, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.022 · Cited by 2
Cross-reactive tissue-resident memory T lymphocytes—concepts, evidence, and open questions
Lei, H., Sun, Y., Gong, W., & Dong, J. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08137-7 · Cited by 1
Gujar, S. A., Pol, J. G., Vijayan, V. V., Nair, P. G., Sheela, U. B., Banerjee, A., & Kroemer, G. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-015132 · Cited by 1
Self-citationMicrobiome–Driven Carcinogenesis and Circulating Microbial Signals in Genitourinary Cancers
Kawashima, A., Jingushi, K., Saito, T., Uemura, T., Yamamoto, A., Sassi, N., Horitani, H., Inoguchi, S., Horibe, Y., Ishizuya, Y., et al. (2026) · Cancer Science · doi:10.1111/cas.70448 · Cited by 1
Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth
Bashir, H., Sanidad, K. Z., Ravisankar, P., Banks, K. M., Bose, A., Yu, S., McGrath, J. J. C., Carrow, H. C., Kim, T. K., Troxell, C. A., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.06.004 · Cited by 3
Cavalluzzo, B., Cembrola, B., Mangano, S., Belli, A., Izzo, F., D'Angelo, R., Chiofalo, M. G., Forte, C. A., Morabito, Calabrese, A., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-09294-9 · Cited by 1
Gut bacteriophages and the pinball challenge
Sordi, L. D. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.02.019 · Cited by 1
Lakshmanan, A. P., Murugesan, S., & Bangarusamy, D. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_4 · Cited by 1
Modulation of tumor environment in colorectal cancer – could gut microbiota be a key player?
Mendes, A. D., Vicente, R. S., Vitorino, M. M., Silva, M., & Costa, D. A. (2022) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2022.1021050 · Cited by 1
Microbiota in Cancer Immunotherapy: The Next Milestone of Immuno-oncology?
Ting, N. L.-N., & Yu, J. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_17 · Cited by 1
Vaccines and active immunization against cancer
Rojas, L. A., & Balachandran, V. P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87763-3.00018-6 · Cited by 2
Gut microbiota and gastrointestinal tumors: insights from a bibliometric analysis
Chen, C., Wang, X., Han, X., Peng, L., & Zhang, Z. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1558490 · Cited by 1
Structural host immune-microbiota interactions
Brito, I., & Kriegel, M. A. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2022.102445 · Cited by 1
Heirali, A., Chen, B., Wong, M., Schneeberger, P. H. H., Rey, V., Spreafico, A., Xu, W., & Coburn, B. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.27.441693
Microbiome and Inflammation in Antibody Deficiency
Berbers, R.-M. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/254
An Impressive End to a Distinguished Career
Fox, B. A., Schaeffer, B. S., & Connelly, J. E. (2006)
The place of virome in women’s reproductive health
Karakhalis, L. Y., Сергеевна, К. Т., & Zhigalenko, A. R. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-14-185-192
Microbiome as a therapeutic target
Moiseenko, F. V. (2022) · Practical oncology · doi:10.31917/2303160
Supplementary Data from Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Derosa, L., Routy, B., Desîlets, A., Daillère, R., Terrisse, S. A., Kroemer, G., & Zitvogel, L. (2023) · doi:10.1158/2159-8290.22540051
Self-citationThe microbiome and cancer immunotherapy
Niederhuber, J. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87763-3.00020-4
Systemic Onco-Sphere: Host Microbiome and Cancer
Saw, P. E., & Song, E. (2023) · Springer eBooks · doi:10.1007/978-981-99-1183-7_25
Abundance of human T-cell epitopes in microbial proteomesPreprint
Kovaleva, V. A., & Zvyagin, I. V. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.29.568792
Intestinal phage-bacteria interactions across scales
Lamy-Besnier, Q. (2021) · theses.fr (ABES) · doi:10.70675/0e6f620fz20adz4df9z947fzccfc8abb9d94
The Association Between Intestinal Flora and Lung Cancer and the Regulatory Role of Dietary Fiber
Wu, H. (2024) · Highlights in Science Engineering and Technology · doi:10.54097/p06r5454
Influence du microbiote intestinal sur la régulation de l'immunosurveillance du cancer
del Socorro, T. P. (2024) · theses.fr (ABES) · doi:10.70675/232b3261z2813z464cz830dz0aed33c39ce7
Causal associations between gut microbiota and cancersPreprint
Yue, Z., Yan, J., Shen, L., Zhao, C., Yang, X., Yao, Y., Song, D., Xu, C., Bi, C., xiong, Z., et al. (2025) · medRxiv · doi:10.1101/2025.02.17.25322359
Mechanisms of action of intestinal microorganisms and advances in head and neck tumors
Su, X., Fa-qiang, M., & Jin, F. (2025) · Discover Oncology · doi:10.1007/s12672-025-02035-y
Ramanathan, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-80029-0_10
Research Advances in the Association between Gut Microbiota and HER2-Positive Breast Cancer
龙, 腾. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1561834
Ragone, C., Mauriello, A., Cavalluzzo, B., Mangano, S., Cembrola, B., Ciotola, N., Buonaguro, L., & Tagliamonte, M. (2025) · Infectious Agents and Cancer · doi:10.1186/s13027-025-00683-x
Sibéril, S., & Teillaud, J. (2025) · médecine/sciences · doi:10.1051/medsci/2025128
Fang, J., Zhang, Y., Wang, W., Zuo, X., Chen, T., Li, K., Yang, H., Zhu, T., Zhang, Y., Wei, D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.22.683275
Lai, J., & Chen, H. (2025) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0114
Nudel, R., Allesøe, R. L., Thompson, W. K., Werge, T., Rasmussen, S., & Benros, M. E. (2021) · Figshare · doi:10.6084/m9.figshare.14707984
Pett, N. (2024) · cIRcle (University of British Columbia) · doi:10.14288/1.0438408 · Cited by 1
Bacteria-based cancer immunotherapy: A re-emerging strategy with contemporary implications
Almonte, A. A. (2023) · ANU Open Research (Australian National University) · doi:10.25911/dnar-rv79
Rao, X., Zhou, R., Li, W., Chai, X., & Zhang, H. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105308
Li, X., Chang, J., Xia, Q., Yan, J., Zhang, H., & Yang, H. (2026) · Microorganisms · doi:10.3390/microorganisms14040807
Host and gut microbiota crosstalk: A new paradigm for colorectal cancer immunotherapy
Ti, D.-D., Liu, P., Wu, C.-Y., Shi, Z., Guo, S.-M., & Gao, Z. (2026) · World Journal of Clinical Oncology · doi:10.5306/wjco.v17.i4.118606
Self-citationGattazzo, F. (2025) · PubliCatt (Università Cattolica del Sacro Cuore) · doi:10.83049/unicatt/publicatt/10807_309857 · Cited by 2
Integration of microbiome data with traditional diagnostics
Siddiqui, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40551-8.00016-0
Making room for gut prophages in human health
Sordi, L. D. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.03.018
Akram, F., Zainab, S., Shabbir, I., & Haq, I. U. (2026) · Folia Microbiologica · doi:10.1007/s12223-026-01515-0
Wang, Y., Li, Z., & Kong, X. (2026) · Cancer Screening and Prevention · doi:10.14218/csp.2026.00033
Microbiome in cancer immunotherapy and cancer progression
Kumavath, R., Athulya, M., & Paul, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43846-2.00006-4
Microbiota and immunotherapy: The birth of a new paradigm?
Newsome, R. C., & Jobin, C. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.06.007
Gouveia, L., Serpa, J., & Mendes, C. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_3
Microbiome testing in gastrointestinal cancers: From microbial signatures to clinical translation
Nikitina, D., Morkūnas, E., Šabanas, P., Jonaitis, P., Urbonas, T., Gedgaudiene, G., Gedgaudas, R., Kupčinskienė, K., Macas, A., Simenas, Š., et al. (2026) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2026.102127
Jinhu, G., Li, Y., Yang, Y., & Wang, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1878878
Alotaibi, B. S. (2026) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-026-00107-w
Hu, S., Shi, G., Zhao, J., Long, X., Tang, L., Qi, Z., Xu, X., Cheng, P., & Liu, J. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.08.021 · Cited by 1
Enterococcus and cancer: from mechanistic insights to clinical translation
Feng, H., Huang, X., Zhuang, Y., Pu, L., Dong, R., & Ren, P. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1882184
Pang, T., Zhou, X., & Ge, Z. (2026) · Metabolites · doi:10.3390/metabo16090638
Mapping the Altered Landscape of TCR Repertoire in Autoimmune Diseases
Albalaa, C., Pezous, M., Klatzmann, D., & Mariotti‐Ferrandiz, E. (2026) · Immunological Reviews · doi:10.1111/imr.70174
Self-citationResearch progress in intratumoral microbiota: unlocking the potential of cancer immunotherapy
Tian, T., & Chen, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1956198
Mei, J., Imin, I., Gao, X., Xue, Y., Xu, K., Zhu, M., Bai, R., & Liu, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.09.033
Beyond molecular mimicry: immune memory as the missing dimension of cancer immune surveillance
Buonaguro, L., & Tagliamonte, M. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-016810
Ecological Editing: Decoupling Microbial Signals from Metabolic Noise to Reprogram the Gut Ecosystem
He, Y., Zhu, X., Huang, Z., Yang, X., & Yi, B. (2026) · Microorganisms · doi:10.3390/microorganisms14102410
Gut bacterial-derived beneficial proteins in intestinal disease
Zhou, S., Tian, Q., Ullah, S., Su, D., Geng, J., & Zhang, M. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128794
Antibiotics and outcomes of cancer immunotherapy: An updated meta-analysis and clinical applications
Porcari, S., Bolte, L. A., Björk, J. R., Elkrief, A., Derosa, L., Ferrari, M., Pezzullo, A. M., Severino, A., Fusco, W. G., Messaoudene, M., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.09.012
Self-citationKhan, A., Tareen, A., Farid, A. A. M., Amin, A., Khan, H. N., Hadi, D. K., Khan, S. R., & Raza, A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1985675
Li, D., Wang, H., Guo, J., Leng, F., Zhi, X., Gong, M., Zeng, M., Liu, K., Sun, Y., Li, Y., et al. (2026) · Science Advances · doi:10.1126/sciadv.aee7661
Metadata
- Authors
- Fluckiger, A., Daillère, R., Sassi, M., Sixt, B. S., Liu, P., Loos, F., Richard, C., Rabu, C., Alou, M. T., Goubet, A.-G., Lemaitre, F., Ferrere, G., Derosa, L., Duong, C. P. M., Messaoudene, M., Gagné, A., Joubert, P., De Sordi, L., Debarbieux, L., Simon, S., Scarlata, C.-M., Ayyoub, M., Palermo, B., Facciolo, F., Boidot, R., Wheeler, R., Boneca, I. G., Sztupinszki, Z., Papp, K., Csabai, I., Pasolli, E., Segata, N., Lopez-Otin, C., Szallasi, Z., Andre, F., Iebba, V., Quiniou, V., Klatzmann, D., Boukhalil, J., Khelaifia, S., Raoult, D., Albiges, L., Escudier, B., Eggermont, A., Mami-Chouaib, F., Nistico, P., Ghiringhelli, F., Routy, B., Labarrière, N., Cattoir, V., Kroemer, G., & Zitvogel, L.
- Affiliations
- Inserm (FR)
- Université de Bourgogne (FR)
- Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Bacteriophage, Bacterium, Host Laboratory, Institut Pasteur, F-75015 Paris, France.
- Institut Pasteur (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Instituto Nazionale Tumori Regina Elena (IT)
- Centre Georges François Leclerc (FR)
- Computational Health Informatics Program (CHIP), Boston Children's Hospital, Boston, MA, USA.
- Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.
- University of Naples Federico II (IT)
- University of Trento (IT)
- Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
- Department of Cancer Medicine, Breast Cancer Committee, Gustave Roussy, Villejuif, France.
- University of Trieste (IT)
- UMR MEPHI, Aix-Marseille Université, IRD, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille cedex 05, France.
- Aix-Marseille Université (FR)
- Institut Gustave Roussy (FR)
- INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Fac. de Médecine - Univ. Paris-Sud, Université Paris-Saclay, 94805, Villejuif, France.
- Unit of Tumor Immunology and Immunotherapy, Department of Research, Advanced Diagnostics and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
- Karolinska University Hospital (SE)
- Corresponding author
- Kroemer, Guido
- Zitvogel, Laurence
- ORCID
- Fluckiger, Aurélie
- Daillère, Romain
- Sassi, Mohamed
- Sixt, Barbara Susanne
- Liu, Peng
- Loos, Friedemann
- Richard, Corentin
- Rabu, Catherine
- Alou, Maryam Tidjani
- Goubet, Anne-Gaëlle
- Lemaitre, Fabien
- Ferrere, Gladys
- Derosa, Lisa
- Duong, Connie P. M.
- Messaoudene, Meriem
- Gagné, Andréanne
- Joubert, Philippe
- De Sordi, Luisa
- Debarbieux, Laurent
- Simon, Sylvain
- Scarlata, Clara-Maria
- Ayyoub, Maha
- Palermo, Belinda
- Facciolo, Francesco
- Boidot, Romain
- Wheeler, Richard
- Boneca, Ivo Gomperts
- Sztupinszki, Zsofia
- Papp, Krisztian
- Csabai, Istvan
- Pasolli, Edoardo
- Segata, Nicola
- Lopez-Otin, Carlos
- Szallasi, Zoltan
- Andre, Fabrice
- Iebba, Valerio
- Quiniou, Valentin
- Klatzmann, David
- Khelaifia, Saber
- Raoult, Didier
- Albiges, Laurence
- Escudier, Bernard
- Eggermont, Alexander
- Nistico, Paola
- Ghiringhelli, François
- Routy, Bertrand
- Labarrière, Nathalie
- Cattoir, Vincent
- Kroemer, Guido
- Zitvogel, Laurence
- Venue
- Science
- Published
- 2020-08-21
- Volume
- 369
- Issue
- 6506
- Pages
- 936-942
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3081393016
- Cited by
- 396
- References
- 53
- Citations by year
- 2026: 47 · 2025: 77 · 2024: 59 · 2023: 80 · 2022: 61 · 2021: 62 · 2020: 9
- FWCI
- 18.57
- Type
- journal article
- Language
- en
- Open access
- green
- inserm.hal.science
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, other-oa)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0015, ANR-19-CE15-0029, ANR-16-RHUS-0008)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- Keywords
- bacteriophages, Enterococcus, cross-reactivity, molecular mimicry, tumor antigens, T cell response, gut microbiota, cancer immunotherapy, anti-PD-1 therapy, chemotherapy, microbial peptides, immune checkpoint inhibitors
- MeSH terms
- Gastrointestinal Microbiome, Enterococcus hirae, Animals, Antibodies, Monoclonal, Epitopes, Antigens, Neoplasm, Bacteriophages, Cross Reactions, Cyclophosphamide, Feces, H-2 Antigens, Humans, Immunotherapy, Neoplasms, Histocompatibility Antigens Class I, Viral Tail Proteins, CD8-Positive T-Lymphocytes, Antineoplastic Agents, Alkylating, Mice, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.